Fundamentals Data provided by Morningstar.Data provided by Morningstar.
52 Week Range
Avg. Volume (1 month)
as at 24 Feb 3:44pm
Why Estia Health Ltd needs to be on your watch list
Why Regis Healthcare Ltd should be on your watch list
The ASX 2014-15 end of financial year review: Top 10 Stocks
Here’s why Estia Health Ltd has skyrocketed 48%: Is it too late to buy?
Lunch time movers and shakers: 8 stocks you need to know about
Will MYOB and 2XU be the hottest IPOs of 2015?
Which ASX healthcare stocks should you buy today?
Here’s why these 6 new S&P/ASX200 stocks deserve your attention
|10 Mar 2022||$0.0352||50.00%||Interim||08 Apr 2022|
|15 Sep 2021||$0.0464||50.00%||Final||30 Sep 2021|
|10 Mar 2021||$0.0200||50.00%||Interim||08 Apr 2021|
|11 Mar 2020||$0.0402||50.00%||Interim||30 Sep 2020|
|11 Sep 2019||$0.0711||100.00%||Final||26 Sep 2019|
|13 Mar 2019||$0.0812||100.00%||Interim||11 Apr 2019|
|11 Sep 2018||$0.0865||100.00%||Final||26 Sep 2018|
|13 Mar 2018||$0.0928||100.00%||Interim||11 Apr 2018|
|01 Sep 2017||$0.1004||100.00%||Final||18 Sep 2017|
|03 Mar 2017||$0.1030||100.00%||Interim||20 Mar 2017|
|02 Sep 2016||$0.0594||100.00%||Final||19 Sep 2016|
|03 Mar 2016||$0.0940||100.00%||Interim||21 Mar 2016|
|03 Sep 2015||$0.1760||64.20%||21 Sep 2015|
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
|Date||Announcement||Price Sensitive?||Time||No. of Pages||File Size|
Regis Healthcare Ltd provides residential care for the elderly in Australia, including respite, dementia-specific, and palliative care. The firm's facilities are primarily located in metropolitan areas and a majority of its rooms offered are single bedrooms. The majority of Regis' revenue comes from government funding due to the highly regulated environment for aged care facilities in Australia, though the firm also receives resident fees.
|05 Jul 2022||$1.90||$0.08||4.40%||78,267||$1.81||$1.90||$1.81|
|04 Jul 2022||$1.82||$0.00||0.00%||142,333||$1.84||$1.89||$1.81|
|01 Jul 2022||$1.82||$-0.03||-1.62%||58,272||$1.87||$1.88||$1.80|
|30 Jun 2022||$1.85||$0.03||1.64%||88,036||$1.82||$1.85||$1.78|
|29 Jun 2022||$1.83||$-0.02||-1.09%||197,867||$1.86||$1.86||$1.79|
|28 Jun 2022||$1.84||$-0.02||-1.08%||87,491||$1.86||$1.86||$1.83|
|27 Jun 2022||$1.86||$-0.02||-1.06%||121,007||$1.85||$1.95||$1.84|
|24 Jun 2022||$1.88||$0.03||1.62%||80,277||$1.85||$1.89||$1.84|
|23 Jun 2022||$1.85||$-0.03||-1.60%||99,259||$1.91||$1.91||$1.85|
|22 Jun 2022||$1.88||$-0.05||-2.59%||158,277||$1.90||$1.92||$1.87|
|21 Jun 2022||$1.93||$0.02||1.05%||43,615||$1.93||$1.93||$1.90|
|20 Jun 2022||$1.91||$-0.05||-2.56%||94,453||$1.90||$1.94||$1.89|
|17 Jun 2022||$1.96||$0.04||2.08%||154,412||$1.92||$1.96||$1.88|
|16 Jun 2022||$1.92||$-0.04||-2.05%||86,921||$1.96||$1.96||$1.89|
|15 Jun 2022||$1.96||$0.03||1.55%||147,076||$1.89||$2.01||$1.87|
|14 Jun 2022||$1.93||$-0.17||-8.10%||355,685||$1.99||$2.03||$1.92|
|10 Jun 2022||$2.10||$0.00||0.00%||185,039||$2.10||$2.15||$2.05|
|09 Jun 2022||$2.10||$0.00||0.00%||447,822||$2.10||$2.11||$2.00|
|08 Jun 2022||$2.10||$-0.03||-1.41%||223,581||$2.14||$2.15||$2.06|
|07 Jun 2022||$2.13||$-0.12||-5.33%||417,546||$2.28||$2.28||$2.09|
|17 Nov 2021||Linda Mellors||Issued||76||$158,400||
Issue of securities. 76,893 - Rights
|Mr Graham Hodges||Non-Executive DirectorNon-Executive Chairman||Aug 2017||
Mr Hodges has international experience in the financial services industry with a career spanning more than 40 years. He commenced his career in Commonwealth Treasury, Canberra, where he worked for approximately 10 years before being seconded to the International Monetary Fund in Washington for several years. For 28 years, Graham built an executive career at the Australian and New Zealand Banking Group Limited and was formerly the Deputy Chief Executive Officer, ANZ Banking Group Ltd. Graham is currently a Director of AmBank Holdings Berhad (stepping down on 2 September 2021) and Assemble Communities Pty Ltd, and was previously Chairman of ANZ SAM Board (Special Assets Management), Esanda, ANZ Wealth, and a member of the Australian Government's Aged Care Financing Authority. He is a member fo the People and Risk Compliance committee.
|Professor Christine Constance Bennett||Non-Executive Director||Mar 2018||
Prof Bennett has over 30 years of health industry experience in clinical care and governance, strategic planning, executive management, teaching and research. She is Deputy Vice Chancellor Enterprise & Partnerships and Head of the School of Medicine, Sydney, at The University of Notre Dame Australia. Christine is also Convenor of the Champions of Change Coalition Health Group and joined the Telstra Health Board in July 2020. Previously, Christine was a Group Executive and Chief Medical Officer at both MBF Limited and Bupa Australia, a Partner in the KPMG Health and Life Sciences Practice, CEO of Westmead Hospital, Chair of the Sydney Children's Hospitals Network and Non-Executive Director of Digital Health CRC Limited. From 2008 to 2010, Christine was Chair of the National Health and Hospitals Reform Commission to provide advice on a long-term plan for the future of the Australian health and aged care system. Prof Bennett is chair of the Chairman of the Clinical Governance and Care Committee.
|Mr Bryan Dorman||Non-Executive Director||May 2007||
Mr Dorman has experience working in enterprises across a broad range of industry sectors, including residential aged care, manufacturing, property development, asset investment and business services. Bryan was a Partner in Melbourne accounting firm Rees Partners from 1977 until 2000 and is a qualified accountant. Bryan is a founding Director and shareholder of Regis. From its commencement in the early 1990s until 2014, Bryan was Chairman (and Executive Chairman until 2008), during which time he oversaw the management and growth of the Group. Bryan was also the National President of the former aged care industry body, The Aged Care Association of Australia, from 2004 to 2012, and was actively involved in the development of the industry and shaping its future. He is a member of the Risk, Compliance, Clinical Governance and Care Committee.
|Mr Ian Gregory Roberts||Non-Executive Director||May 2007||
Mr Roberts has over 30 years of experience in the real estate sector including 20 years in residential aged care. Prior to co-leading the Regis journey, Ian was involved in property development (sub-divisional and commercial) in South East Queensland. Ian is currently a Non-Executive Director of several property and property services enterprises. He is a member of the People committee.
|Dr Linda Jane Mellors||Chief Executive OfficerManaging Director||Aug 2019||
Mr Mellors has nearly 20 years of executive experience in health and aged care. Prior to joining Regis, Linda held a range of roles in hospital and health systems in Victoria, as well as a national aged care service. Linda is currently a Board Director of Mackillop Family Services and inaugural Chair of the Aged Care Reform Network. Linda was formerly the Chair of the Aged Care Guild, Co-Chair of the Victorian Metropolitan Hospital Chief Executive group, Chair of the North Eastern Metropolitan Integrated Cancer Service, Board Member of the Parent Infant Research Institute and Board Director of the South West Melbourne Medicare Local.
|Ms Sally Margaret Freeman||Non-Executive Director||Jan 2022||
Ms Freeman has career spans over 25 years, having worked as a Partner at KPMG and Ernst & Young, with a focus on audit and risk management. She has consulted across many levels of both the public and private sectors and worked in London, Singapore, Perth and Melbourne. Sally is currently a non-executive Director of ASX-listed Netwealth Group Limited (including Chair of the Audit Committee) and Netwealth Superannuation Services. Sally is also a non-executive Director of Eastern Health, the Regional Investment Corporation, and the Melbourne Football Club and is an independent member of the audit committees at Healthshare Victoria, Caulfield Grammar School and Commonwealth Games Australia. Sally will also chair the Risk and Compliance Committee of REG.
|Ms Rebecca Dean||Company Secretary||Jul 2020||
|Mr Malcolm Peter Ross||Company SecretaryGeneral Counsel||Nov 2021||
|Imtiaz Bhayat||Chief Information Officer||
|Gregg Funston||Executive General Manager Support Services||
|Rick Rostolis||Chief Financial Officer||
|Rebecca Dean||Company Secretary||
|Malcolm Peter Ross||Company SecretaryGeneral Counsel||
|Melissa McDonald||Executive General Manager Clinical and Care Practice||
|Gaylene Coulton||Executive General Manager Operations - QLD/NSW/NT/Retirement Living||
|Catherine Buttigieg||Executive General Manager People and Culture||
|Filomena Ciavarella||Executive General Manager Strategy Quality and Improvement||
|Paul Cohen Executive||General Manager Operations - VIC/SA/WA/TAS/Home Care||
|Ashburn Pty Ltd Acn 005 883 438||81,910,479||27.23%|
|Galabay Pty Ltd Acn 010 849 153||81,910,479||27.23%|
|Citicorp Nominees Pty Limited||26,330,445||8.75%|
|HSBC Custody Nominees (Australia) Limited||22,550,947||7.50%|
|Buttonwood Nominees Pty Ltd||13,768,346||4.58%|
|J P Morgan Nominees Australia Pty Limited||8,717,028||2.90%|
|Mr David Qian Lee||5,303,888||1.76%|
|BNP Paribas Noms Pty Ltd||3,501,408||1.16%|
|Mr Ross James Johnston||2,245,000||0.75%|
|Mr Vincent Michael O'Sullivan||2,192,000||0.73%|
|Bki Investment Company Limited||1,807,428||0.60%|
|BNP Paribas Nominees Pty Ltd||1,763,889||0.59%|
|Cs Fourth Nominees Pty Limited||1,447,626||0.48%|
|National Nominees Limited||1,298,033||0.43%|
|Australian Executor Trustees Limited||1,246,449||0.41%|
|UBS Nominees Pty Ltd||1,165,082||0.39%|
|Bundarra Trading Company Pty Ltd||852,671||0.28%|
|HSBC Custody Nominees (Australia) Limited (i)||850,000||0.28%|
|Ballian Investments Pty Ltd||787,934||0.26%|
|Canto Holdings Pty Ltd||785,548||0.26%|
|Netwealth Investments Limited||783,742||0.26%|